COVID-19 表型：主导还是误导？
COVID-19 phenotypes: leading or misleading?
机构信息
Dept of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany
Dept of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, and Division of Asthma, Allergy and Lung Biology, King's College London, London, UK.
出版信息
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.02195-2020. Print 2020 Aug.
Abstract
摘要
[文献链接]
相似文献
1
COVID-19 phenotypes: leading or misleading?COVID-19 表型：主导还是误导？
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.02195-2020. Print 2020 Aug.
2
[Misleading obsession to number of deaths with Covid-19].[对新冠病毒肺炎死亡人数的误导性执念]
Lakartidningen. 2020 Aug 28;117:28 aug 2020.
3
Misleading Numbers: Is the Risk of Acute Kidney Injury with COVID-19 Truly This Low?误导性数字：新冠病毒感染所致急性肾损伤的风险真的有这么低吗？
Am J Nephrol. 2020;51(7):574-575. doi: 10.1159/000508088. Epub 2020 Jun 29.
4
Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.新冠病毒肺炎患者女性生殖道中严重急性呼吸综合征冠状病毒2的评估：一项前瞻性研究。
J Biol Regul Homeost Agents. 2020;34(5):1885-1888. doi: 10.23812/20-352-L.
5
The Impact of COVID-19 on Italy: A Lesson for the Future.新冠疫情对意大利的影响：未来之鉴。
Int J Occup Environ Med. 2020 Jul 10;11(3):151-152. doi: 10.34172/ijoem.2020.1984. Epub 2020 Mar 30.
6
[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].基于严重急性呼吸综合征（SARS）尸检的新型冠状病毒肺炎（COVID-19）分析
Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.
7
Treatments for COVID-19: emerging drugs against the coronavirus.新冠病毒病的治疗方法：对抗冠状病毒的新型药物
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
8
[COVID-19-never waste a crisis?!].[新冠疫情——切莫浪费一场危机？！]
Radiologe. 2020 Oct;60(10):891-892. doi: 10.1007/s00117-020-00750-x.
9
Treatments for COVID-19: emerging drugs against the coronavirus - reply.新型冠状病毒肺炎的治疗方法：对抗冠状病毒的新型药物——回复
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
10
The duration of SARS-CoV-2 shedding in patients recovering from COVID-19.新型冠状病毒肺炎康复患者中严重急性呼吸综合征冠状病毒2的病毒脱落持续时间。
Epidemiol Mikrobiol Imunol. 2020 Summer;69(3):148-151.
引用本文的文献
1
Does the IL-6/KL-6 ratio distinguish different phenotypes in COVID-19 Acute Respiratory Distress Syndrome? An observational study stemmed from prospectively derived clinical, biological, and computed tomographic data.IL-6/KL-6比值能否区分新型冠状病毒肺炎急性呼吸窘迫综合征的不同表型？一项基于前瞻性收集的临床、生物学和计算机断层扫描数据的观察性研究。
PLoS One. 2025 May 21;20(5):e0321533. doi: 10.1371/journal.pone.0321533. eCollection 2025.
2
Interpretable clinical phenotypes among patients hospitalized with COVID-19 using cluster analysis.使用聚类分析对COVID-19住院患者的可解释临床表型进行研究。
Front Digit Health. 2023 Apr 11;5:1142822. doi: 10.3389/fdgth.2023.1142822. eCollection 2023.
3
Lessons Learned in Mechanical Ventilation/Oxygen Support in Coronavirus Disease 2019.在 2019 冠状病毒病机械通气/氧支持方面的经验教训。
Clin Chest Med. 2023 Jun;44(2):321-333. doi: 10.1016/j.ccm.2022.11.010. Epub 2022 Nov 22.
4
Ten golden rules for individualized mechanical ventilation in acute respiratory distress syndrome.急性呼吸窘迫综合征个体化机械通气的十条黄金法则。
J Intensive Med. 2021 Feb 5;1(1):42-51. doi: 10.1016/j.jointm.2021.01.003. eCollection 2021 Jul.
5
Heterogeneity of Ventilation/Perfusion Mismatch at Different Levels of PEEP and in Respiratory Mechanics Phenotypes of COVID-19 ARDS.不同呼气末正压水平及新型冠状病毒肺炎急性呼吸窘迫综合征呼吸力学表型下通气/灌注不匹配的异质性
Respir Care. 2023 Jan 30;68(2):188-198. doi: 10.4187/respcare.10242.
6
Mortality and Pulmonary Embolism in Acute Respiratory Distress Syndrome From COVID-19 vs. Non-COVID-19.新型冠状病毒肺炎与非新型冠状病毒肺炎所致急性呼吸窘迫综合征的死亡率及肺栓塞情况
Front Med (Lausanne). 2022 Mar 4;9:800241. doi: 10.3389/fmed.2022.800241. eCollection 2022.
7
Subphenotyping of Mexican Patients With COVID-19 at Preadmission To Anticipate Severity Stratification: Age-Sex Unbiased Meta-Clustering Technique.COVID-19 墨西哥患者入院前亚表型分析以预测严重程度分层：年龄性别无偏荟萃聚类技术。
JMIR Public Health Surveill. 2022 Mar 30;8(3):e30032. doi: 10.2196/30032.
8
Airway pressure release ventilation in mechanically ventilated patients with COVID-19: a multicenter observational study.新型冠状病毒肺炎机械通气患者的气道压力释放通气：一项多中心观察性研究。
Acute Crit Care. 2021 May;36(2):143-150. doi: 10.4266/acc.2021.00017. Epub 2021 May 4.
9
A Perspective on COVID-19 Management.关于新冠病毒疾病管理的观点
J Clin Med. 2021 Apr 9;10(8):1586. doi: 10.3390/jcm10081586.
10
Ten things you need to know about intensive care unit management of mechanically ventilated patients with COVID-19.关于 COVID-19 机械通气患者的重症监护病房管理，你需要知道的十件事。
Expert Rev Respir Med. 2021 Oct;15(10):1293-1302. doi: 10.1080/17476348.2021.1906226. Epub 2021 Apr 6.
本文引用的文献
1
The perils of premature phenotyping in COVID-19: a call for caution.新冠疫情中过早表型分析的风险：呼吁谨慎行事。
Eur Respir J. 2020 Jul 23;56(1). doi: 10.1183/13993003.01768-2020. Print 2020 Jul.
2
Management of COVID-19 Respiratory Distress.新型冠状病毒肺炎呼吸窘迫的管理
JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.
3
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
Zotero 插件